131 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
10
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity.
University of Bayreuth
1
Identification of the Binding Site of Chroman-4-one-Based Sirtuin 2-Selective Inhibitors using Photoaffinity Labeling in Combination with Tandem Mass Spectrometry.
University of Gothenburg
17
Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring N
Jiangsu University
2
Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity.
University of Paris
34
How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
Guru Jambheshwar University of Science and Technology
79
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.
University of Minnesota
9
Simple N(e)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
Jiangsu University
43
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.
Albert-Ludwigs-University of Freiburg
14
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.
University of Genoa
9
Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.
Northwestern University
13
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
Methylgene
3
Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells.
Istituto Ortopedico Rizzoli (Ior)
22
Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.
National University of Singapore
17
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
The University of Tokyo
10
Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.
University of Gothenburg
19
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
University of Minnesota
5
Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
Universiti Sains Malaysia
26
Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
Northwestern University
6
Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.
Fred Hutchinson Cancer Research Center
3
Identification of novel SIRT2-selective inhibitors using a click chemistry approach.
Nagoya City University
4
Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Universiti Sains Malaysia
3
Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cells.
University of Eastern Finland
39
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Sirtris A Gsk
40
Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.
Chinese Academy of Sciences
2
Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.
San Francisco State University
13
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
Sapienza University of Rome
3
Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.
University of Hyderabad Campus
15
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.
Sapienza University of Rome
20
SIRT1 modulation as a novel approach to the treatment of diseases of aging.
Sirtris A Gsk
8
Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors.
University of Gothenburg
76
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
Kyoto Prefectural University of Medicine
7
Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
Ludwig-Maximilians-Universit£T M£Nchen
4
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
Sirtris Pharmaceuticals
21
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
Albert-Ludwigs-University of Freiburg
7
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.
University of Kuopio
6
N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.
University of Kuopio
22
Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.
University of St. Andrews
21
Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
University of Eastern Finland
3
A mechanism-based potent sirtuin inhibitor containing Ne-thiocarbamoyl-lysine (TuAcK).
University of Akron
8
Computer- and structure-based lead design for epigenetic targets.
Martin-Luther University of Halle-Wittenberg
10
Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins).
Ernst-Moritz-Arndt University Greifswald
4
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Cemm-Research Center For Molecular Medicine of The Austrian Academy of Sciences
8
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.
Sapienza University of Rome
6
Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD).
University of East Anglia
15
N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
University of Eastern Finland
3
Chemical probes for histone-modifying enzymes.
Johns Hopkins University School of Medicine
12
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.
Institute of Psychiatry and Neuroscience of Paris
2
Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
Nagoya City University
23
N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
University of Kuopio
11
Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
University of Kuopio
3
Design, synthesis and therapeutic evaluation of novel antimalarial derivatives based on the clinical antitumor candidate drug Quisinostat.
East China University of Science and Technology
64
Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer.
Shenyang Pharmaceutical University
3
Novel xanthone derivatives as potent sirtuin 2 inhibitors.
Jagiellonian University Medical College
22
Thioamides in medicinal chemistry and as small molecule therapeutic agents.
University of Michigan
14
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment.
Guizhou Medical University
6
Design, synthesis and biological evaluation of novel SIRT3 inhibitors targeting both NAD+ and substrate binding sites for the treatment of acute myeloid leukemia.
Shihezi University
24
Design and synthesis of sirtinol analogs as human neutrophil elastase inhibitors.
Chang Gung University
20
A Mitochondria-Targeting SIRT3 Inhibitor with Activity against Diffuse Large B Cell Lymphoma.
Cornell University
19
Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2.
University of Freiburg
16
Ligand-based design and synthesis of new trityl histamine and trityl cysteamine derivatives as SIRT2 inhibitors for cancer therapy.
South Valley University
9
Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
Harvard Medical School
23
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.
Leipzig University
18
Design, synthesis and biological evaluation of 2,4,6- trisubstituted triazine derivatives as new nonpeptide small-molecule SIRT5 inhibitors.
Xihua University
63
Structure-Activity Relationship Studies of 2,4,5-Trisubstituted Pyrimidine Derivatives Leading to the Identification of a Novel and Potent Sirtuin 5 Inhibitor against Sepsis-Associated Acute Kidney Injury.
Xihua University
2
Bioisosteric replacement of 1H-1,2,3-triazole with 1H-tetrazole ring enhances anti-leukemic activity of (5-benzylthiazol-2-yl)benzamides.
University of Lviv
20
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.
Albert-Ludwigs-University of Freiburg
4
Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.
University of Kuopio
59
Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs.
Mansoura University
21
Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020.
Minia University
9
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.
University of Coimbra
72
The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.
Aligarh Muslim University
24
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.
Elixir Pharmaceuticals
5
Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
Sapienza University of Rome
37
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.
Sapienza University of Rome
36
Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors.
China Pharmaceutical University
17
An in silico approach to discovering novel inhibitors of human sirtuin type 2.
University of Kuopio
4
Drug Repurposing of Quisinostat to Discover Novel
East China University of Science and Technology
5
Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer.
Guizhou Medical University
37
Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library.
The University of Hong Kong
61
Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1.
Max Planck Institute of Molecular Physiology
54
Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates.
Xihua University
1
Single-step fluorescent probes to detect decrotonylation activity of HDACs through intramolecular reactions.
City University of Hong Kong
3
Simultaneous Inhibition of SIRT2 Deacetylase and Defatty-Acylase Activities via a PROTAC Strategy.
Cornell University
7
Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition.
University of Copenhagen
3
A Set of Highly Sensitive Sirtuin Fluorescence Probes for Screening Small-Molecular Sirtuin Defatty-Acylase Inhibitors.
Nagoya City University
12
Synthesis of indole inhibitors of silent information regulator 1 (SIRT1), and their evaluation as cytotoxic agents.
University of Paris
11
Structure activity study of S-trityl-cysteamine dimethylaminopyridine derivatives as SIRT2 inhibitors: Improvement of SIRT2 binding and inhibition.
Science Farm
48
Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors.
Chinese Academy of Sciences
4
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.
Xihua University
20
Recent advances in the discovery of potent and selective HDAC6 inhibitors.
Shandong University
9
A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring N
Fudan University
3
Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.
Sichuan University
13
Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Sichuan University
6
Unexpected small molecules as novel SIRT2 suicide inhibitors.
Engineering Research Center For The Development and Application of Ethnic Medicine and Tcm (Ministry of Education)
6
Recent applications of hydantoin and thiohydantoin in medicinal chemistry.
College of Pharmacy and Gachon Institute of Pharmaceutical Science
34
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Sichuan University
14
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.
TBA
9
Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.
Cairo University
8
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.
Umr Cnrs 7285
9
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.
Wuhan Institute of Technology
17
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors.
Chinese Academy of Sciences
6
Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD
Kyoto Prefectural University of Medicine
20
Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from
University of Freiburg
88
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.
Imperial College
20
Human SIRT3 tripeptidic inhibitors containing N(ε)-thioacetyl-lysine.
Jiangsu University
8
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.
Imperial College London
20
Development of Peptide-Based Sirtuin Defatty-Acylase Inhibitors Identified by the Fluorescence Probe, SFP3, That Can Efficiently Measure Defatty-Acylase Activity of Sirtuin.
Nagoya City University
38
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.
Nestle Skin Health
8
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).
University of Freiburg
4
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.
University of Genoa
40
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
West China School of Pharmacy
12
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.
H�Pital Kirchberg
4
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
Xihua University
13
PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Wuhan Humanwell Innovative Drug
21
Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers
Redx Pharma
290
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
Merck Sharp & Dohme